A Biacore S51 SPR biosensor instrument (GE Healthcare) was used to characterize interactions between conjugates with known on- or off-target proteins. Human recombinant protein kinase ABL1 (ThermoFisher/Life Technologies) (20 μg/ml in 20 mM HEPES, pH 7.5) was immobilized directly on a CM5 biosensor chip surface by amine coupling, to a level of about 5000 RU. EGFR kinase domain L858R (ThermoFisher/Life Technologies) was immobilized directly on the biosensor chip surface by an amine-coupling procedure (32 μg/ml in 10 mM sodium acetate buffer, pH 4.0) resulting 11 000 RU. The running buffer contained: 50 mM Tris–HCl pH 7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM MnCl2, 0.005% Tween-20. A 1:1 serial dilution of drug conjugates was injected over immobilized ABL1 at concentrations ranging from 0.06 to 2 μM. All experiments were performed at a flow rate of 30 μl/min and at 25°C and data was analyzed using Biacore S51 Evaluation software (GE Healthcare).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.